Chronic Kidney Disease and Antiretroviral Therapy in HIV-Positive Individuals: Recent Developments
出版年份 2016 全文链接
标题
Chronic Kidney Disease and Antiretroviral Therapy in HIV-Positive Individuals: Recent Developments
作者
关键词
HIV, HAART, cART, Kidney, Renal, Tenofovir, Antiretroviral therapy, Dual therapy, GFR, Proteinuria
出版物
Current HIV/AIDS Reports
Volume 13, Issue 3, Pages 149-157
出版商
Springer Nature
发表日期
2016-04-30
DOI
10.1007/s11904-016-0315-y
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Higher tenofovir exposure is associated with longitudinal declines in kidney function in women living with HIV
- (2016) Sanjiv M. Baxi et al. AIDS
- Tenofovir alafenamide: A novel prodrug of tenofovir for the treatment of Human Immunodeficiency Virus
- (2016) Adrian S. Ray et al. ANTIVIRAL RESEARCH
- Elevations in Serum Creatinine With Tenofovir-Based HIV Pre-Exposure Prophylaxis
- (2016) Rabi Yacoub et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Reversibility of Glomerular Renal Function Decline in HIV-Uninfected Men and Women Discontinuing Emtricitabine-Tenofovir Disoproxil Fumarate Pre-Exposure Prophylaxis
- (2016) Kenneth K. Mugwanya et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority study
- (2016) Anthony Mills et al. LANCET INFECTIOUS DISEASES
- Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study
- (2016) Amanda Mocroft et al. Lancet HIV
- Dual Therapy Treatment Strategies for the Management of Patients Infected with HIV: A Systematic Review of Current Evidence in ARV-Naive or ARV-Experienced, Virologically Suppressed Patients
- (2016) Jean-Guy Baril et al. PLoS One
- Nonalbumin proteinuria predominates in biopsy-proven tenofovir nephrotoxicity
- (2015) Meghan E. Sise et al. AIDS
- Kidney disease in antiretroviral-naïve HIV-positive adults with high CD4 counts: prevalence and predictors of kidney disease at enrolment in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial
- (2015) AC Achhra et al. HIV MEDICINE
- Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials
- (2015) Paul E Sax et al. LANCET
- Dual treatment with lopinavir–ritonavir plus lamivudine versus triple treatment with lopinavir–ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial
- (2015) José R Arribas et al. LANCET INFECTIOUS DISEASES
- Dual treatment with atazanavir–ritonavir plus lamivudine versus triple treatment with atazanavir–ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial
- (2015) José A Perez-Molina et al. LANCET INFECTIOUS DISEASES
- An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) study
- (2015) Nina Friis-Møller et al. European Journal of Preventive Cardiology
- Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study
- (2015) Amanda Mocroft et al. PLOS MEDICINE
- Changes in Glomerular Kidney Function Among HIV-1–Uninfected Men and Women Receiving Emtricitabine–Tenofovir Disoproxil Fumarate Preexposure Prophylaxis
- (2015) Kenneth K. Mugwanya et al. JAMA Internal Medicine
- Time trends for risk of severe age-related diseases in individuals with and without HIV infection in Denmark: a nationwide population-based cohort study
- (2015) Line D Rasmussen et al. Lancet HIV
- Long-term exposure to tenofovir continuously decrease renal function in HIV-1-infected patients with low body weight
- (2014) Takeshi Nishijima et al. AIDS
- Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis
- (2014) Marc M. Solomon et al. AIDS
- Cross-sectional Comparison of the Prevalence of Age-Associated Comorbidities and Their Risk Factors Between HIV-Infected and Uninfected Individuals: The AGEhIV Cohort Study
- (2014) J. Schouten et al. CLINICAL INFECTIOUS DISEASES
- Clinical Practice Guideline for the Management of Chronic Kidney Disease in Patients Infected With HIV: 2014 Update by the HIV Medicine Association of the Infectious Diseases Society of America
- (2014) Gregory M. Lucas et al. CLINICAL INFECTIOUS DISEASES
- Dolutegravir: Clinical and Laboratory Safety in Integrase Inhibitor–Naive Patients
- (2014) L. Curtis et al. HIV CLINICAL TRIALS
- Incomplete Reversibility of Estimated Glomerular Filtration Rate Decline Following Tenofovir Disoproxil Fumarate Exposure
- (2014) Sophie Jose et al. JOURNAL OF INFECTIOUS DISEASES
- Ritonavir-boosted darunavir combined with raltegravir or tenofovir–emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial
- (2014) François Raffi et al. LANCET
- Moving Away from Ritonavir, Abacavir, Tenofovir, and Efavirenz (RATE) - Agents That Concern Prescribers and Patients: A Feasibility Study and Call for a Trial
- (2014) Amit C. Achhra et al. PLoS One
- Renal impairment in HIV-infected patients initiating tenofovir-containing antiretroviral therapy regimens in a Primary Healthcare Setting in South Africa
- (2014) Monika Kamkuemah et al. TROPICAL MEDICINE & INTERNATIONAL HEALTH
- Predictors of advanced chronic kidney disease and end-stage renal disease in HIV-positive persons
- (2013) Lene Ryom et al. AIDS
- Association Between Antiretroviral Exposure and Renal Impairment Among HIV-Positive Persons With Normal Baseline Renal Function: the D:A:D Studya
- (2013) L. Ryom et al. JOURNAL OF INFECTIOUS DISEASES
- The validity of the modification of diet in renal disease formula in HIV-infected patients: a systematic review
- (2013) Willemijn L. Eppenga et al. JOURNAL OF NEPHROLOGY
- Tenofovir Effect on the Kidneys of HIV-Infected Patients: A Double-Edged Sword?
- (2013) J. Tourret et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Antiretroviral regimens sparing agents from the nucleoside(tide) reverse transcriptase inhibitor class: a review of the recent literature
- (2013) Amit C Achhra et al. AIDS Research and Therapy
- Risk Factors for ESRD in HIV-Infected Individuals: Traditional and HIV-Related Factors
- (2011) Vasantha Jotwani et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Comparison of CKD-EPI and MDRD to estimate baseline renal function in HIV-positive patients
- (2011) Fowzia Ibrahim et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients
- (2010) Amanda Mocroft et al. AIDS
- Cost‐Effectiveness of Tenofovir as First‐Line Antiretroviral Therapy in India
- (2010) Melissa A. Bender et al. CLINICAL INFECTIOUS DISEASES
- Systematic Review and Meta‐analysis: Renal Safety of Tenofovir Disoproxil Fumarate in HIV‐Infected Patients
- (2010) Ryan D. Cooper et al. CLINICAL INFECTIOUS DISEASES
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started